Fatty liver disease (MASLD/MASH): open trials in Netherlands

15 open trials have a site in Netherlands. Registry data; only the trial team decides who can take part.

NCT06632444
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Trial Treatment · Phase 3 · Boehringer Ingelheim
Amsterdam UMC Stichting, Amsterdam · Albert Schweitzer Ziekenhuis, Dordrecht · Leids Universitair Medisch Centrum (LUMC), Leiden · Radboud universitair medisch centrum Stichting, Nijmegen · Sint Franciscus Vlietland Groep Stichting, Rotterdam · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam · Stichting Elisabeth-TweeSteden Ziekenhuis, Tilburg · Universitair Medisch Centrum Utrecht, Utrecht
Registry updated 2026-10-28
NCT06632457
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Trial Treatment · Phase 3 · Boehringer Ingelheim
Albert Schweitzer Ziekenhuis, Dordrecht · Leids Universitair Medisch Centrum (LUMC), Leiden · Radboud universitair medisch centrum Stichting, Nijmegen · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam · Sint Franciscus Vlietland Groep Stichting, Rotterdam · Stichting Elisabeth-TweeSteden Ziekenhuis, Tilburg · Bernhoven B.V., Uden · Universitair Medisch Centrum Utrecht, Utrecht
Registry updated 2026-10-28
NCT06318169
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Trial Treatment · Phase 3 · Hoffmann-La Roche
Amsterdam UMC Stichting, Amsterdam · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam · Universitair Medisch Centrum Utrecht, Utrecht
Registry updated 2026-10-23
NCT06419374
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Trial Treatment · Phase 3 · Hoffmann-La Roche
Stichting Amsterdam UMC, Amsterdam · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam · Stichting Elisabeth-TweeSteden Ziekenhuis, Tilburg · Universitair Medisch Centrum Utrecht, Utrecht
Registry updated 2026-10-23
2026-525755-82-00
A pivotal clinical study to investigate the safety and efficacy of efimosfermin compared with placebo in adult participants with compensated cirrhosis due to Metabolic dysfunction-associated steatohepatitis (MASH)
Trial Treatment · Phase 3 · Glaxosmithkline Research & Development Limited
Amsterdam UMC Stichting, Amsterdam · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam · Bernhoven B.V., Uden
Registry updated 2026-10-19
2026-525757-37-00
A study to investigate safety and efficacy of efimosfermin compared with placebo in adult participants with compensated cirrhosis (stage F4 fibrosis) due to MASH (NEBULA-2)
Trial Treatment · Phase 3 · Glaxosmithkline Research & Development Limited
Amsterdam UMC Stichting, Amsterdam · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam · Bernhoven B.V., Uden
Registry updated 2026-10-19
NCT07165028
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Trial Treatment · Phase 3 · Eli Lilly and Company
Amsterdam UMC, locatie AMC, Amsterdam · Radboudumc, Nijmegen · Erasmus Medisch Centrum, Rotterdam · Progress Clinical Research Den Bosch, 's-Hertogenbosch · Universitair Medisch Centrum Utrecht, Utrecht · Progress Clinical Research Zwolle, Zwolle
Registry updated 2026-10-08
NCT07221188
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Trial Treatment · Phase 3 · GlaxoSmithKline
Amsterdam UMC Stichting, Amsterdam · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam · Bernhoven B.V., Uden
Registry updated 2026-09-17
NCT06845345
Effect of an Early Time Restricted Eating Mediterranean Diet Compared to Naltrexone/Bupropion on Liver Fibrosis in People With Cardiometabolic Risk Factors in a Hospital Outpatient Clinic (MEDFAST-study)
Trial Treatment · Phase 4 · Carmen Dietvorst
Sint Franciscus Vlietland Groep Stichting, Rotterdam
Registry updated 2026-04-21
NCT07326865
Hepatic Gene Response to Intravenous Glucose in Obese Patients With and Without MASLD Undergoing Bariatric Surgery
Trial Treatment · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
AMC, Amsterdam
Registry updated 2026-01-08
NCT05651724
Global Research Initiative for Patients Screening on MASH
Research · Julius Clinical
Amsterdam UMC, Amsterdam · Franciscus Gasthuis & Vlietland, Rotterdam
Registry updated 2024-08-01
NCT06061042
Effect of Timed-Restricted Eating on Metabolic Health
Trial Treatment · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Amsterdam UMC, location AMC, Amsterdam
Registry updated 2023-09-29
NCT04442334
The European NAFLD Registry
Research · Newcastle University
Amsterdam UMC, Amsterdam
Registry updated 2023-01-06
NCT04190849
European Paediatric Non-Alcoholic Fatty Liver Disease Registry (EU-PNAFLD)
Research · Cambridge University Hospitals NHS Foundation Trust
Maastricht UMC, Maastricht
Registry updated 2022-03-04
NCT02422238
Prospective Cohort, With Biobanking, of Patients With Nonalcoholic Fatty Liver Disease
Research · Maastricht University Medical Center
Maastricht University Medical Center, Maastricht
Registry updated 2016-09-13

All Fatty liver disease (MASLD/MASH) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error